GNF-8625 monopyridin-N-piperazine (hydrochloride)
Selected Variant
HY-131706A-01
Size: 5 mg
GNF-8625 monopyridin-N-piperazine hydrochloride (TRKi-2), a TRK inhibitor, which is from the patent WO 2020038415 A1[1].
Product Specifications
CAS Number
2412055-62-8
UNSPSC
12352005
Target
Trk Receptor
Type
Reference compound
Related Pathways
Neuronal Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/gnf-8625-monopyridin-n-piperazine-hydrochloride.html
Purity
99.74
Solubility
DMSO : 6.67 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
FC1=CC([C@@H]2N(C3=NN4C(C=C3)=NC=C4C5=NC(N6CCNCC6)=CC=C5)CCC2)=CC=C1.[H]Cl
Molecular Formula
C25H27ClFN7
Molecular Weight
479.98
References & Citations
[1]By Liu, Jing, et al. Preparation of tropomyosin receptor kinase degradation compounds and methods of use. WO 2020038415 A1.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Price
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Anti-EHD1 Antibody Picoband®, Dylight594 Conjugate
TRIM29 (TRIM29/1041), CF740 conjugate, 0.1mg/mL
Anti-Hsp70/HSPA1A/HSPA1B Antibody Picoband® (Cy3 Conjugate)
MUC4 (Mucin 4 / Gastric Mucin) (MUC4/3105), 0.2mg/mL
Glycophorin A / CD235a (Erythrocyte Marker) (rGYPA/280), CF405S conjugate, 0.1mg/mL
